Royal Sense distributes medical consumables, surgical instruments, and pharmaceutical products primarily to government hospitals and private healthcare institutions across India.
The company lacks a durable moat as it operates primarily as a trading intermediary in a highly fragmented market with low entry barriers. While it has established relationships with government entities via the GeM portal, the 9.3% net margin and 13% ROCE are modest for a capital-light trading business, suggesting a lack of significant pricing power or cost advantage.
Management has focused on consolidating proprietorship entities into a single corporate structure and pursuing an IPO to fund working capital. Recent moves include a preferential warrant issue and a proposed merger with TTG Innovations to expand the product pipeline, though the merger faced initial regulatory rejection.
The business collapsed as the working capital cycle became a terminal trap. While revenue appeared to grow, the cash conversion ratio of 0.19 proved to be a harbinger of phantom profits; the company was essentially shipping goods to government entities and never collecting the cash. The inventory buildup observed in 2025 continued until the balance sheet was bloated with obsolete stock, while the failed merger with TTG Innovations signaled a management team more interested in financial engineering and related-party shuffling than operational excellence. As liquidity dried up, the lack of a moat allowed leaner competitors to underbid them on the GeM portal, leaving the company with high debt and no pricing power.
RichFakir rates Royal Sense Ltd's business quality as mediocre — 49/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Royal Sense Ltd is trading about 35% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Royal Sense Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Royal Sense Ltd's fair value is about ₹115 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →